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The function of apolipoprotein (apo) Cl in vivo is not well 
understood. From in vitro studies it has been reported that an 
excess of apoCl relative to apoE inhibits receptor-mediated 
uptake of remnant lipoproteins [Sehayek and Eisenberg (1991) 
J. Biol. Chem. 2 6 6 , 22453-22459]. In order to gain a better 
understanding of the role of apoCl in lipoprotein metabolism in 
vivo, we have generated apoC 1 -deficient mice by gene targeting 
in embryonic stem cells. Homozygous mutant mice are viable 
and do not show overt abnormalities. Serum triacylglycerol 
levels are increased by 60 % on both a standard mouse diet and 
a mild hypercholesterolaemic diet compared with controls. Total 
serum cholesterol levels are similar to controls on the two diets. 
However, the level of high-density lipoprotein cholesterol in the 
apoCl -deficient mice fed on the mild hypercholesterolaemic diet
is slightly decreased, which is accompanied by a 3-fold increase 
in very-low-density plus low-density lipoprotein (VLDL + LDL) 
cholesterol. On a severe atherogenic diet, the homozygous apoC l- 
deficient mice become hypercholesterolaemic, with a serum 
cholesterol level of 10.7±3.3 mM compared with 6.7±1.8 mM 
and 5.1 ±  1.6 mM in heterozygous and control mice respectively. 
The increase in cholesterol is mainly confined to the 
VLDL-f-LDL-sized fractions. Binding experiments revealed that 
lipoproteins lacking apoCl with d <  1.006 g/ml are poor com­
petitors for 125I-labelled LDL binding to the LDL receptor on 
HepG2 cells. This suggests that total apoCl deficiency leads to 
impaired receptor-mediated clearance of remnant lipoproteins 
rather than enhanced uptake, as was expected from data reported 
in the literature.
INTRODUCTION
The human APOC1 gene is located within a gene cluster on 
chromosome 19q together with APOE, pseudo-APOCl and 
APOC2 [1], Apolipoprotein (apo) Cl is a polypeptide of 57 
amino acid residues with a calculated molecular mass of 6.6 kDa 
[2], cDNA analysis has indicated that apoCl is synthesized with 
a 26-residue signal peptide which is cleaved from the protein 
during intracellular processing [3], The major site of production 
is the liver [4], In plasma, the concentration of apoCl is about
6 mg/dl and it principally resides on chylomicrons, very-low-
lipoproteins (VLDLs) and high-density 
(HDLs) [5].
Although the function of apoCl in vivo is not well understood, 
in vitro studies have shown that it is able to activate the enzyme 
lecithin cholesterol acyltransferase [6]. Furthermore, it can block 
the apoE-mediated binding of apoE-enriched /?-VLDLs to the 
low-density lipoprotein (LDL) receptor [7] and to the LDL 
receptor-related protein (LRP) [8], Inhibition of binding by 
apoCl can be due to either displacement of apoE from the 
remnant particle or interaction of apoCl with apoE on the 
lipoprotein surface. In summary, these studies suggest that 
hepatic uptake of remnants is governed by a balance between the 
amounts of apoE and apoCl on the lipoprotein particle.
To identify elements controlling the tissue-specific expression 
of the APOE APOC1 gene cluster, several transgenic mouse lines
have been generated [9], An APOC1 gene construct containing 
the entire region between the APOC1 gene and the APOCL 
pseudogene was expressed at high levels in liver of transgenic 
mice. These animals exhibited slightly elevated plasma cholesterol 
levels, whereas plasma triacylglycerols were 2- to 3-fold higher 
than in control mice. In contrast, transgenic mice expressing 
both the human APOE and APOC1 genes had normal plasma 
lipid levels. These results are in agreement with in vitro experi­
ments mentioned above, showing that an excess of apoCl relative 
to apoE on the lipoprotein particle inhibits the binding of these 
particles to lipoprotein receptors [7,8,10].
Taken together, all insights into the function of apoCl so far 
suggest a modulating role of apoCl in lipoprotein metabolism. A 
more direct function remains unclear. To date, no impairment of 
lipoprotein metabolism has been identified that is known to be 
associated with mutation in the APOC 1 gene. Therefore, to clarify 
the metabolic role of apoCl, we decided to generate apoCl - 
deficient mice by gene targeting in mouse embryonic stem (ES) 
cells. Homozygous null mutants are viable and show slightly 
elevated triacylglycerol levels in animals fed on both a standard 
mouse diet and a mild hypercholesterolaemic diet. However, on 
a severe atherogenic diet, the apoCl-deficient mice develop 
hypercholesterolaemiacompared with controls. An accumulation 
of VLDL+ LDL-sized particles is observed on this diet, which 
could be explained by the decreased binding efficiency of mutant 
d < 1.006 g/ml lipoproteins to the LDL receptor. This suggests
from overlapping human APOE and APOC1 genomic fragments that complete apoCl deficiency leads to impaired receptor
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mediated clearance of remnant lipoproteins rather than enhanced 
uptake, as was expected from data reported in the literature.
M ATER IALS AND M ETHODS 
Construction of targeting vector
A replacement-type targeting vector was derived from an 8.8 kb 
EcoRl fragment spanning the entire Apocl gene, subcloned from 
an Apoe-cl-c2 cluster carrying 129 Sv/Ev mouse cosmid clone 
[11]. It was designed to disrupt the endogenous Apocl gene by 
replacing a 0.7 kb BamHl-Saml  fragment, containing exons 1 
and 2 (including the translational start site [12]) and part of exon 
3, with a 2.0 kb hygromycin B-resistance (hygroBr) gene [13]. 
The resulting construct had segments of 3.3 and 4.8 kb with 5' 
and 3' homology to the endogenous Apocl locus. A herpes 
simplex virus thymidine kinase (HSV-tk) gene [14] was placed at 
the 3' end of the vector, to enable the application of a positive-
*  Jk -A Jk
negative-selection strategy [15] (Figure 1). Both selectable genes 
were placed in the same transcriptional orientation as the Apocl 
gene.
ES cell culture and transfection
E14 ES cells [16], kindly provided by Dr. Plump, Rockefeller 
University, New York, NY, U.S.A., were cultured and sub­
sequently selected on hygroBr mouse embryonic fibroblasts 
derived from mice deficient in muscle creatine kinase [17], as 
described by Robertson [18]. Batches of about 4 x 106-8  x 10® ES 
cells were electroporated in 0.4 ml of electroporation buffer 
(10 mM potassium phosphate, pH 7.2, 0.25 M sucrose, 1 mM 
MgCl2, 200 ¡i%/ml BSA) in the presence of 10 /¿g/ml linearized 
vector DNA at 4.0kV/cm in a TA750 transfection apparatus 
(Kriiss G.m.b.H., Hamburg, Germany). Selection with 
250 /¿g/ml hygromycin B (ICN Biochemicals, Cleveland, OH, 
U.S.A.) and 0.2 pM  (1 -(2-deoxy-2-fluoro-/?-D-arabinofuranosyl)- 
5-iodouracil) (F1AU) (Bristol Myers, New York, NY, U.S.A.) in 
ES cell culture medium [Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 15% fetal calf serum, 2mM  
glutamine, 1 mM sodium pyruvate and 0.1 mM 2-mercapto- 
ethanol] was applied 24 h after transfection. To determine the 
enrichment factor of the negative selection, a few plates were 
cultured with selection medium without F1AU. Individual 
double-resistant colonies were picked in 96-well plates at day 10 
and expanded to 24-well plates. Each clone in a confluent well 
was split into two equal parts for storage and Southern-blot 
analysis.
Generation of chlmaeric and apod-deficient mice
Targeted clones were injected into C57BL/6 recipient blastocysts, 
and embryos were transferred to the uterine horns of (C57BL/6 
x CBA/Ca)Fl pseudopregnant females [19]. The extent of 
chimaerism was determined by the degree of agouti coat colour 
contribution. Male chimaeras were mated with C57BL/6 females, 
and germline transmission was scored by the presence of agouti 
fur in the offspring. Transmission of the apoCl mutation was 
assessed by genomic Southern-blot analysis of tail-tip DNA. 
Heterozygous mutants were interbred to obtain homozygous 
apoC 1-deficient mice. All mice used in this study were littermates 
derived from matings of heterozygotes, and were 9-13 weeks of 
age at the onset of the study. Animals were bred and housed 
under standard conditions in the Transgenic Animal Facilities of 
the Central Animal Laboratory of the Medical Faculty, Nijmegen 
University.
Genomic Southern-blot analysis
ES cells were lysed in 0.5 ml of 0.5 M Tris/HCl, pH 9.0, 
containing 20 mM EDTA, 10 mM NaCl, 1 % SDS and 100 /tg/ml
proteinase K at 55 °C overnight. DNA was purified by phenol 
extraction and ethanol precipitation. Tail-tip DNA was prepared 
as previously described [20].
Approx. 5 p,g portions of DNA were digested with ifm dlll, 
and DNA fragments were resolved on 0.7 % (w/v) agarose gels, 
transferred to Biotrace HP nylon membranes (Gelman Sciences, 
Ann Arbor, MI, U.S.A.) and hybridized to probe A, which is 
located 5' to the targeting vector (see Figure 1). Genomic probes 
were isolated by random subcloning of a Sau 3 A-digested cosmid, 
carrying the Apoe-cl-c2 cluster.
Northern-blot analysis
Total RNA was isolated from liver using the RNAZOL procedure 
(Cinna/Biotecx, Houston, TX, U.S.A.). RNA samples (10 /¿g 
per lane) were size-separated by electrophoresis through a 
denaturing agarose gel (1.2%, w/v) containing 7.5% formal­
dehyde and transferred to a nylon membrane (Hybond-N+; 
Amersham, Bucks., U.K.) according to the manufacturer’s 
recommendations. Blots were subsequently hybridized with 
a 32P-labelled mouse Apocl cDNA probe (derived from 
mAPOClcl6, see ref. [12]) and a rat glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) cDNA probe at 55 °C in a solution 
containing 55% formamide [21]. The intensity of the hybrid­
ization signal was quantified with a Phosphor Imager 
(Molecular Dynamics), using the software program Image-
quant (Molecular Dynamics). The level of expression in the
* '  ■ ' i i ^
heterozygotes and homozygotes was compared with wild-types 
and related to the level of internal standard (GAPDH).
Lipoprotein isolation
The individual lipoprotein fractions (VLDL, d < 1.006; inter- 
mediate-density lipoprotein-1-LDL, d — 1.006-1.063; HDL, 
d <  1.063-1.21 g/ml) were isolated from pooled serum, com­
posed of sera of at least nine starved mice per group. Isolation 
was achieved by sequential ultracentrifugation at the respective 
densities at 84 000 g (40000 rev./min) overnight* using a Ti-50 
fixed-angle rotor (Beckman, Geneva, Switzerland), followed by 
dialysis at 4 °C overnight against PBS, pH 7.4. The amount of 
protein was determined by the method of Lowry et al. [22]. 
Human LDLs were isolated as described by Redgrave et al. [23].
Western-blot analysis
From each lipoprotein fraction, samples of 5 f ig  of protein were 
analysed by SDS/PAGE using 4-20% gradient gels. Proteins 
were transferred to nitrocellulose membranes (Schleicher and 
Schuell, Dassel, Germany) followed by incubation with poly­
clonal rabbit anti-(mouse apoAl), -apoCl, -apoC3 or -apoE 
(kindly provided by Dr. Weisgraber, Gladstone Foundation 
Laboratories for Cardiovascular Disease, San Francisco, CA, 
U.S.A.). Goat anti-rabbit IgG conjugated to peroxidase (Nordic 
Immunology, Tilburg, The Netherlands) was used as secondary 
antibody, and detection was by the immunoperoxidase procedure 
using 4-chloro-1-naphthol as substrate.
Analysis of lipid and lipoprotein
After an overnight period without food (16-17 h), approx. 200 [A 
of whole blood was obtained from each mouse via tail bleeding. 
Levels of total serum cholesterol and triacylglycerol (without
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stabilized immediately by the addition of 1 % HSA and then 
extensively dialysed against culture medium [DMEM supple­
mented with 20 mM Hepes buffer (pH 7.4) and 10 mM NaHCOJ.
Measurement of competition of lipoproteins with 125l-labeiled LD L 
for binding to HepG2 cells
HepG2 cells were cultured in 24-well plates as previously 
described [25]. About 24 h before the start of the experiment, 
DMEM supplemented with l % HSA instead of fetal calf serum 
was added to the cells. Competition experiments were performed 
by incubating HepG2 cells for a period of 4  h at 0 °C with 1251- 
labelled LDL (10 /¿g/ml of protein) in the presence or absence of 
increasing amounts of unlabelled lipoproteins, as indicated. After 
removal of the medium, cells were washed three times with ice- 
cold PBS containing 0.1% (w/v) BSA, followed by one wash 
with PBS without BSA. Cells were then dissolved in 1 ml of 
0.2 M NaOH. Protein content was measured by the method of 
Lowry et al. [22]. The radioactivity in a portion of the sample 
represents the binding.
Figure 1 Strategy for the disruption of the mouse Ap o cl gene Diets
Schematic diagram showing (a ) the structure oi the endogenous Apod locus, (b) the targeting 
vector and (c ) the predicted structure of the Apod locus after homologous recombination. 
Numbers 1 -4  and the closed boxes denote exon sequences, and the bars Indicate the positions 
of probes A, B and C. Abbreviations: B, BamWY, E, fcoR i; H. M w dlll; S, Sami
measuring free glycerol) were determined using Boehringer- 
Mannheim enzymic assay kit no. 236691 and Sigma GPO- 
Trinder kit no. 337-B respectively. Triacylglycerols, free chol­
esterol and phospholipids in the individual lipoprotein fractions 
were measured with Boehringer-Mannheim enzymic assay kits 
nos. 701904 and 310328 and an analytical kit (B) from Wako 
Chemicals G.m.b.H. (Neuss, Germany) respectively. Cholesterol 
esters are total cholesterol minus free cholesterol.
For f.p.l.c. size fractionation of lipoproteins, 200 //I of pooled 
serum from at least nine starved mice per group was injected on 
to a 25 ml of Superóse 6 preparation-grade column (Pharmacia,
Mice were given free access to water and food. Before starting 
the dietary treatment, mice were fed a regular breeding chow diet 
(RMH-B) containing 6.2 % fat. The two semisynthetic diets were 
made up essentially as described by Nishina and co-workers [26], 
and were purchased from Hope Farms, Woerden, The 
Netherlands. Between 2 and 3 months of age, mice were put on 
a mild high-fat/cholesterol (HFC) diet for 3 weeks. This diet 
contained 15 % cocoa butter, 0.25 % cholesterol, 40.5% sucrose, 
10% cornstarch, 1%, corn oil and 6% cellulose. Afterwards, 
they were fed a severe high-fat/cholesterol diet (HFC0.5%) for 
at least 3 weeks, containing 15 % cocoa butter, 1 % cholesterol, 
0.5 % cholate, 40.5 % sucrose, 10 % cornstarch, 1 % corn oil and 
4.7 % cellulose (all percentages are by weight).
R ES U LTS
Generation of apoC1-deficient mice
Uppsala, Sweden), and eluted at a constant flow rate of A replacement-type targeting vector was prepared as described in
0.5 ml/min with PBS, pH 7.4. The effluent was collected in the Materials and methods section, and the selection strategy is
0.5 ml fractions, and cholesterol and triacylglycerol concen- shown in Figure 1. This construct was transfected into E14ES
trations were measured enzymically in each fraction, as described cells [16]. Targeted clones were identified by hybridizing Southern
above. Lipoproteins were identified on the basis of the elution blots of //mdlll-digested DNA with probe A, which is located
profile of human serum lipoproteins. The relative distribution of just upstream of the Eco R I  site flanking the 5' border of the
cholesterol among the VLDL+ LDL- and the HDL-sized frac- targeting construct (Figure 1). Correctly targeted clones, yielding
tions was calculated from the area under the curve in f.p.l.c. a new diagnostic 9.3 kb fragment together with the endogenous
fractions 14-23 and 24-33 respectively. 8.0 kb band (Figure 2a), were observed at fairly high frequency
To evaluate the size distribution of VLDL-sized particles more (about 1:5, with an enrichment factor of approx. 6 gained by
specifically, 200 ¡A of pooled serum from at least nine starved 
mice per group was injected on to a Bio-Gel A 150 m column
mti-tk  selection). To obtain further evidence that the targeting 
vector had integrated via a genuine homologous recombination
(operating range 10« to 150 x 10« kDa) (Bio-Rad, Richmond, event, Hindlll- and EcoRl-digested blots were also hybridized
CA, U.S.A.), and eluted at a constant flow rate of 0.1 ml/min 
with PBS, pH 7.4.
with a hygroB'-specific probe (B) and a probe (C) in the 3' arm 
of the targeting construct (see Figure 1; blotting results not 
shown). No abnormal targeting events were scored.
A total of eight targeted E14 ES cell lines were injected into 
C57BL/6 host blastocysts, and embryos weiLabelling of human L D L  with 1Z6I
Immediately after isolation, human LDLs were labelled by the 
m ICl method as described by Bilheimer et al. [24], followed by
dialysis against PBS (4 x 500 ml) at 4 °C overnight. They were mutation through the germline. 
then stabilized by adding human serum albumin (HSA) (1 %, interbred to generate mice deficient in apoCl with a mixed
C57BL/6 females, 
md males derived from one clone were found to transmit the
us mutants were
w/v). The m I-labelled LDLs were stored at 4 °C, and used within C57BL/6 129/Ola Figure 2(b) shows an
1 week. Specific radioactivity was about 200 c.p.m/ng of lipo- example of the genotype of these animals. The mutation
protein protein. When not labelled with 12BI, lipoproteins were Mendel i
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Figure 2 Identification of targeted ES  cells and apoC1 -deficient mice
Southern-blot analysis of genomic DNA Isolated from ES cells (a ) and mouse tall tips (b ) 
digested with HinM  and hybridized with probe A (see Figure 1). DNA size (kb) is Indicated, 
(c ) Northern-blot analysis of 10/¿g of RNA per lane prepared from mouse livers hybridized 
with an apod cDNA probe and a GAPDH cDNA probe. +  /  +  , normal ES cell DNA or control 
mice; + /  — .targeted EScell DNA or heterozygous apoCI-deficient mice; — /  — .homozygous 
apoCI -deficient mice.
total of 98 offspring, 20 were wild-types, 51 heterozygotes and 27 
null mutants.
To confirm that the targeted mutation had indeed generated 
the desired apoCI deficiency, a Northern-blot analysis of RNA 
prepared from liver was hybridized with a mouse Apocl cDNA 
probe. No Apocl mRNA was detectable in homozygous apoCl- 
deficient mice, and heterozygotes had a reduced level of ex­
pression compared with controls (Figure 2c).
Alteration of serum lipid levels in heterozygous and homozygous 
apoCI-deficient mice in response to diet
Total serum triacylglycerols were slightly increased in hetero­
zygous and homozygous apoCI-deficient mice on a chow diet, 
whereas serum cholesterol levels did not show any significant 
change (Table 1). The increase in triacylglycerols was found in 
the VLDL + LDL-sized fractions, as determined by f.p.l.c. analy­
sis (Figure 3a). The distribution of cholesterol among the 
VLDL + LDL- and HDL-sized fractions is presented in Table 1, 
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Figure 3 Lipoprotein profiles of apoCI-deficient and control mice on chow 
and two different hypercholesterolaemic diets
Sera from at least nine starved controls, heterozygous and homozygous apoCI -deficient mice 
were pooled and separated on the basis of size by f.p.l.c, Mice had been fed on a standard 
mouse chow (a), a mild hypercholesterolaemic diet (HFC, containing 0.25% cholesterol) (b) 
or a severe hypercholesterolaemic diet (HFCO.5%, containing 1 % cholesterol and 0.5% cholate) 
(c). Fractions 14-23 represent VLDL+LDL and fractions 24-33 represent HDL (based on the
elution profile of human serum lipoproteins). , Cholesterol; triacylglycerol. On the
HFCO.5% diet, triacylglycerol levels were too low to be detected.
Table 1 Serum cholesterol and triacylglycerol levels in apoCI -deficient mice
Results In parentheses are percentage of total serum cholesterol. H -/ +  , Control mice; + /  — , heterozygous apoCI -deficient mice; — / — , homozygous apoCI-deficient mice; HFC, mild high- 
fat/cholesterol diet with 0.25% cholesterol; HFCO.5%, severe high-lat/cholesterol diet, containing 1% cholesterol and 0.5% cholate (see the Materials and methods section); N.D., not detectable. 
*P <  0.05 compared with + /  +  mice on the same diet using the non-parametric Mann-Whitney ¿/test; t P <  0.05 compared with +  / -  mice on the same diet using non-parametric 
Mann-Whitney U test.
No. of Serum lipid concentration (mM) Lipoprotein cholesterol (mM)
Genotype analysed Diet Total cholesterol Triacylglycerols VLD L+LD L HDL
H- /  + 10 Chow 3.0 ± 0 .6 0.2 ±  0.1 0 . 0 ( d ) 3.0 ( >  99)
+  / - 10 Chow 3.0 ± 0 .4 0.4 ±  0.1 * 0.1 (3) 3.0 (97)
— /  — 10 Chow 2.4 ± 0 .3 0.4 ±  0.2* 0.1 (3) 2.3 (97)
+  /  + 10 HFC 3.9 ± 1 .0 0.6 ±  0.4 0.3 (8) 3.6 (92)
-I- /  — 10 HFC 3.9 ± 0 .6 0.7 ± 0 .3 0.5 (13) 3.4 (87)
9 HFC 4.0 ± 0 .5 1.1 ±  0.4 * t 0.6 (16) 3.4 (84)
4" /  + 10 HFCO.5% 5.1 ± .1 .6 N.D. 2.2 (43) 2.9 (57)
j 10 HFCO.5% 6.7 ±  1.8 N.D. 3.8 (56) 2.9 (44)
i>wi j  mp* 9 HFCO.5% 1 0 .7 ± 3 .3 * f N.D. 6,8 (64) 3.9 (36)
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Hardly any cholesterol was detectable in the VLDL-LDL-sized 
fractions.
To investigate the response of apoC 1-deficient mice on a 
hypercholesterolaemic diet, mice were fed on two types of high- 
fat diet. The HFC and HFC0.5 % diets were considered to be 
mildly and severely hypercholesterolaemic, respectively (see the 
Materials and methods section). The latter diet contained 0.5 % 
cholate, which facilitates intestinal uptake of fat and cholesterol. 
After 3 weeks on the HFC diet, total serum levels of cholesterol 
and triacylglycerol were increased among all groups compared 
on the chow diet (Table 1). At this time, plasma lipid levels had 
reached a plateau level (not shown). Again, the serum triacyl- 
glycerols in the homozygotes were slightly elevated (1.6-fold) 
compared with wild-type mice. This increment was confined to 
the VLDL+LDL-sized fractions, as is shown by the f.p.l.c. 
patterns (Figure 3b). There was no significant difference in serum 
triacylglycerol level among controls and heterozygotes. Total 
cholesterol levels were similar for all groups on the HFC diet. 
However, on this diet the relative amount of cholesterol in the 
VLDL + LDL-sized fractions of the apoC 1-deficient mice had 
doubled compared with wild-type animals (from 8 to 16%; see 
Table 1). Thus, in the absence of apoCl protein, the HFC diet 
causes a shift from HDL cholesterol towards VLDL +  LDL 
cholesterol.
When the animals were fed on the HFC0.5% diet, this shift 
was even more pronounced. Remarkably, serum cholesterol 
levels in homozygotes were then increased to 10.7 +  3.3 mM 
compared with 6.7 ± 1.8 and 5.1 +1.6 mM in heterozygous and 
control mice respectively, whereas serum triacylglycerols had 
declined below detectable level (Table 1). Lowering of triacyl­
glycerol levels concomitant with an increase in serum cholesterol 
in mice on a severe hypercholesterolaemic diet is a common 
phenomenon, and has previously been observed by us [27] and 
others [28,29). The lipoprotein profile had changed for all animals 
fed on the HFC0.5% diet (Figure 3c). In homozygotes in
a dramatic shift of cholesterol from HDL- to 
VLDL + LDL-sized particles occurred (64°
43“
/
particles in homozygotes might even be underestimated, because 
the LDL and HDL fractions were not completely separated 
(Figure 3c). Thus the homozygous apoCl -deficient mice are 
more susceptible to a severe hypercholesterolaemic diet than 
heterozygous and wild-type mice, as demonstrated by an in­
creased accumulation of VLDL +  LDL-sized particles.
a compared with 
o in controls). This accumulation of VLDL + LDL-sized
Table 2 Lipid composition of serum lipoproteins in apoC1-defiGient mice
Lipid levels were measured in concentrated lipoprotein fractions, derived from pooled serum of 
at least nine starved mice per group on HFCO.5% diet, as described in the Materials and 
methods section. Because the samples are concentrated, triacylglycerols are now detectable (not 
detectable in Table 1). TG, Triacylglycerols; FC, free cholesterol; CE, cholesterol ester; PPL, 
phospholipids. +  /  +  , control mice; +  /  — , heterozygous apoCl-deficient mice; — / — , 
homozygous apod-deficient mice,
Lipid composition 
(% of total by weight)
Zygosity
Serum density 
fraction (g/ml) TG FC CE PPL
(PPL +  FC)/ 
(TG +  CE) 
(w/w)
H" /  -J” d <  1.006 26 5 60 8 0.16
d <  1.006-1.063 9 10 71 11 0.26
~f" /  -f" d <  1.063-1.21 12 4 64 19 0.31
-f* /  *"■* d <  1.006 9 8 74 9 0.20
~f” /  — d <  1.006-1.063 6 10 72 12 0.28
4* /  — d <  1.063-1.21 6 5 73 16 0.27
d <  1.006 18 8 66 9 0.20
--  /  -- d <  1.006-1.063 6 12 70 12 0.31
--  /  -- d <c 1.063—1.21 15 7 63 15 0.28
* Low ratio may be due to contamination with LDL.
(a)
+/+ 4~/ 1 —/■
.<i m b , "  < ti ,
Cl •If C3
(b)
+/’+* +'/— —/ —









Figure 4 Western-blot analysis of mouse lipoproteins
Lipoproteins of d < 1.006 g/ml from controls ( +  / + ), heterozygous ( + / — ) and homozygous 
( — /  — ) apoCl-deficient mice were isolated by ultracentrifugation and subjected to SDS/PAGE 
(4-20%  gradient gels) and transferred to a nitrocellulose membrane (5 /¿g of protein per lane). 
The filter was Incubated with polyclonal rabbit anti-(mouse apoCl) (a),  anti-(mouse apoC3) (b), 
anti-(mouse apoE) (c) and antkmouse apoA1) (d) antibodies.
Effect of apoCl deficiency on lipid composition of the individual 
lipoprotein fractions
To investigate whether the effect of apoCl deficiency on serum 
lipid levels was accompanied by a change in the lipid composition 
of the different lipoprotein fractions, the respective lipoproteins 
were isolated by sequential ultracentrifugation. Lipoprotein 
particles from mice fed on the HFCO.5% diet were chosen 
because the striking hypercholesterolaemia in the apoC 1 -deficient 
mice was only observed on this diet. The relative lipid com­
positions of the individual lipoprotein fractions are shown in 
Table 2. The mass ratio of phospholipids + free cholesterol over 
triacylglycerols + cholesterol esters was calculated and taken as a 
measure of mean particle size. No clear difference was found 
between the ratios of the homozygous mice and the respective 
ratios observed for heterozygous and control mice fed on the 
HFC0.5 % diet. VLDL and LDL particles isolated from wild- 
type mice on chow are, as expected, a lot richer in triacylglycerol 
and poorer in cholesterol than the particles that accumulate in
mice on the HFC0.5 % diet, and are smaller in size than after the 
HFCO.5% diet (results not shown).
Serum of mutant mice and controls was also applied to a Bio- 
Gel A 150 m column, which enables measurement of the size 
distribution of the VLDL fraction. No di 
tribution between VLDL from
s m s
s, heterozygous and
wild-type mice could be identified (results not shown).
Effects of apoCl deficiency on apolipoprotein composition
To evaluate whether the effect of apoCl deficiency could be 
explained by a change in apolipoprotein distribution, VLDLs 
(c/ < 1.006 g/ml) were isolated from starved heterozygous, homo­
zygous and control animals fed on the HFCO.5% diet and 
subjected to SDS/PAGE. Western-blot analysis of 11 < 1.006 g/ 
ml particles using an antibody against mouse apoCl, as 
expected, showed that apoCl was com absent
from the homozygous mutant animals and was reduced in 
heterozygotes compared with control mice (Figure 4a). The effect 
of apoCl deficiency on the distribution of apoC3, apoE and
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Figure 5 Competition by normal and apoCI-deficient V L D L  and human 
L D L  for 12Sl-labelled L D L  binding to H e p G Z cells
HEPG2 cells were grown to confluence in 24-well plates, Measurement of the ability of VLDL
(d <  1.006 g/ml) control ( + / + ; - ), heterozygous ( + /
( ) apoCI -deficient mice as well as human LDL (
— ) and homozygous 
) to compete with 1Z5I-
labelled human LDL for receptor binding to HepG2 cells is described in the Materials and 
methods section. Values representing binding as a percentage of the binding In the absence 
of unlabelled lipoprotein (100%). Binding of each lipoprotein sample was carried out in triplicate. 
Each value represents the mean±S.D, The non-saturable component, measured as a 20-fold 
excess of unlabelled lipoproteins, was 23 +  1,31 ± 2 ,  3 4 ± 1  and 3 7 ± 2 %  for LDL, control, 
heterozygous and homozygous VLDL respectively. Comparable results were obtained when the 
lipoproteins were added on the basis of amount of cholesterol.
apoAl on d <  1.006 g/ml particles was also investigated by 
Western-blot analysis (Figures 4b-4d). No clear changes were 
observed in the amount of apoC3 and apoE present on these 
particles. However, apoAl appeared in the d  <  1.006 fraction of 
mutant mice, and about twice the amount of apoAl was found 
in homozygotes compared with heterozygous apoCI -deficient 
mice (Figure 4d). When a Western blot of total lipoproteins 
(d < 1.21 g/ml or d <  1.063-1.21 g/ml) was incubated with anti­
bodies against mouse apoAl, apoC3 and apoE, no overt changes 
were measured in these apolipoprotein concentrations in null 
mutants compared with controls (results not shown).
Impaired binding of apoCI-deflclent V L D L  to the L D L  receptor
To find out whether the accumulation of VLDL+LDL-sized
or a mild hypercholesterolaemic diet was rather subtle. However, 
when the animals were fed on the severe atherogenic diet 
HFC0.5 %, the homozygous apoCI-deficient mice became hyper­
cholesterolaemic compared with wild-type mice.
A mild hypertriglyceridaemia was observed in the null mutants 
on chow and the HFC diet. This weak phenotype could possibly 
be explained by a decreased suitability of apoCI-deficient chylo­
microns and VLDL as substrate for lipoprotein lipase, and is the 
subject of further investigation.
The mild hypertriglyceridaemia was measured in serum of 
starved mice. The duration of starvation is of importance, as 
recent data from LeBoeuf and co-workers [30] have demonstrated 
that plasma triacylglycerol levels paradoxically increase in mice 
during starvation and the level of increase is related to the period 
of starvation. Furthermore, triacylglycerol levels fall significantly 
with time since blood samples were taken, presumably because of 
an active lipase present in mouse plasma [31]. Because of the 
relatively minimal metabolic consequences under mild dietary 
conditions, we have standardized as much as possible analysis of 
triacylglycerols with respect to period of food deprivation and 
time of analysis after sampling. However, at present it cannot be 
ruled out that, even though control samples have been treated in 
exactly the same way, the mild hypertriglyceridaemia observed in 
homozygous apoCI-deficient mice on mild diets is caused by a 
difference in lipase activity in serum samples of apoCI-deficient 
mice and controls.
When the animals were challenged with a severe atherogenic 
diet, the homozygous apoC 1-deficient mice clearly developed 
hypercholesterolaemia. This phenotype is not as severe as 
observed in, for example, apoE-deficient mice [20,32], indicating 
that the function of apoCI in lipoprotein metabolism is not as 
critical as that of apoE. However, the hypercholesterolaemia in 
the A pod  knock-out mice is observed when compared with wild- 
type littermates treated in exactly the same way, demonstrating 
that the high serum cholesterol levels are caused either directly or 
indirectly by deficiency in apoCI.
The observed hypercholesterolaemia after dietary treatment 
was opposite to what one would expect from the literature. In 
vitro studies have shown that apoE can be displaced from (1- 
VLDL by apoCI, resulting in a reduced binding efficiency of the 
particles to the LDL receptor [7] and the LRP [8]. In addition, 
apoCI can inhibit the uptake of triacylglycerol emulsions or 
chylomicron remnants by the perfused rat liver [10,33]. These 
results suggest that the plasma clearance of remnants is retarded 
by an excess of apoCI on the surface of the particle. This is 
consistent with results from in vivo experiments demonstrating 
that transgenic mice overexpressing human apoCI exhibit mod­
erate increases in total plasma cholesterol and triacylglycerol
particles on the HFC0.5 % diet is due to disturbed binding of levels compared with control animals [9].
lipoprotein remnants to the LDL receptor, the ability of isolated 
d < 1.006 g/ml lipoproteins from mice fed on the HFC0.5 % diet 
to compete with human m I-labelled LDL for binding to the 
LDL receptor on HepG2 cells was determined. Figure 5 shows 
that control mouse VLDL competed as efficiently as human 
LDL with 125I-labelled LDL. Strikingly, the d<  1.006 g/ml 
particles from homozygous apoCI-deficient mice were poor 
competitors for 126I-labelled LDL binding to the receptor. 
Heterozygous VLDL was an intermediate competitor.
DISCUSSION
Very little is known about the in vivo function of apoCI in 
lipoprotein metabolism. To clarify its metabolic role, we have 
generated mice deficient in apoCI by gene targeting in ES cells. 
The effect of the null mutation on lipid levels of mice fed on chow
Similarly, excess amounts of apoC3 can interfere with the 
apoE-mediated clearance of remnant lipoproteins. Both in vitro 
experiments [7,10] and in vivo studies with transgenic mice 
overexpressing human apoC3 [34,35] have shown that an excess 
of apoC3 can also inhibit the clearance of remnant lipoproteins, 
although less efficiently than apoC 1. It has been suggested that 
apoCI and apoC3 either displace apoE from the particle or 
interact directly or indirectly with apoE on the lipoprotein 
surface [7,8,35].
In line with this reasoning, we expected that apoC 1 deficiency 
would lead to an acceleration of remnant lipoprotein removal via 
apoE-mediated processes, resulting in normal or even reduced 
serum levels of cholesterol and triacylglycerol. Paradoxically, 
instead of a decrease, a moderate to strong increase in levels of 
VLDL + LDL-sized lipoproteins was found, depending on the 
diet administered. Binding-competition experiments revealed
Apolipoprotein C1 -deficient mice 911
that apoC 1-deficient d < 1.006 g/ml lipoproteins do not bind 
efficiently to the LDL receptor (see Figure 5), suggesting a 
retarded plasma clearance of lipoprotein remnants in mutant 
mice. The reduced binding efficiency could be due to changes in 
the apolipoprotein composition of these particles. The apoE 
concentration of the d < 1.006 lipoproteins of the mutant mice 
was not reduced, but was similar to controls (see Figure 4). Also 
apoC3, which can displace apoE and cause hypertriglyceridaemia 
when over-expressed in mice [34,35], did not substitute for the 
deficient apoCI on the lipoproteins. However, apoAl was present 
in the d < 1.006 g/ml fraction of A pod  null mutants. The 
appearance of apoAl on d < 1.006 g/ml lipoproteins has also 
been observed in apoE-deficient mice [20,32], suggesting that 
apoAl replaces lacking apolipoproteins on VLDL and LDL 
particles in general. Whether the presence of apoAl can modulate 
the apoE-mediated receptor binding is the subject of further 
investigation.
In summary, from our results we conclude that the complete 
absence of apoCI on the chylomicron and VLDL particles leads 
to impaired receptor-mediated clearance of remnant lipoproteins 
rather than an enhanced uptake, as expected from in vitro and in 
vivo studies reported in the literature [7-10]. Obviously, the 
amount of apoCI relative to apoE influences the efficiency of 
hepatic uptake of remnant lipoproteins in a discontinuous way.
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